ClinicalTrials.Veeva

Menu

Multicenter Quantitative and Qualitative Study of the Determinants of Participation in a Cytomegalovirus Preventive Vaccine Study in France in Women Aged 18 to 40 Years Old.

C

Centre Hospitalier Universitaire de Saint Etienne

Status

Not yet enrolling

Conditions

Recruitment

Treatments

Other: Qualitative interview
Other: Quantitative questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT06511635
IRBN432024/CHUSTE

Details and patient eligibility

About

During a vaccine clinical trial of Cytomegalovirus (CMV) vaccine, one of the participants' motivations was to prevent an infection responsible for malformations in a future child. Would their attitude towards a vaccine trial be the same in the context of a vaccine designed to protect them individually? By improving the knowledge of clinical research and determinants in women aged 18 to 40, this study could improve recruitment methods in this specific population for future vaccine trials within the CIC1408 infectious diseases and vaccinology area at Saint-Etienne University Hospital.

Enrollment

306 estimated patients

Sex

Female

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Womens between 18 to 40 included in CMVCTORY vaccine trial

Exclusion criteria

  • Refusal

Trial design

306 participants in 1 patient group

Women between 18 to 40 included in CMVCTORY vaccine trial
Description:
Women between 18 to 40 included in CMVCTORY vaccine trial will be included.
Treatment:
Other: Quantitative questionnaire
Other: Qualitative interview

Trial contacts and locations

1

Loading...

Central trial contact

Nelly JACQUEMET, nurse

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems